Chimerix ROE 2011-2019 | CMRX

Current and historical return on equity (ROE) values for Chimerix (CMRX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Chimerix ROE for the three months ending March 31, 2019 was -36.85%.
Chimerix ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $-0.07B $0.16B -37.67%
2018-12-31 $-0.07B $0.18B -36.65%
2018-09-30 $-0.07B $0.19B -36.63%
2018-06-30 $-0.08B $0.19B -35.05%
2018-03-31 $-0.07B $0.21B -31.91%
2017-12-31 $-0.07B $0.22B -29.22%
2017-09-30 $-0.07B $0.24B -26.12%
2017-06-30 $-0.07B $0.25B -24.91%
2017-03-31 $-0.07B $0.26B -24.16%
2016-12-31 $-0.08B $0.28B -25.83%
2016-09-30 $-0.10B $0.29B -32.04%
2016-06-30 $-0.11B $0.30B -34.57%
2016-03-31 $-0.12B $0.31B -34.13%
2015-12-31 $-0.12B $0.34B -34.36%
2015-09-30 $-0.10B $0.37B -30.41%
2015-06-30 $-0.08B $0.40B -30.30%
2015-03-31 $-0.07B $0.26B -31.52%
2014-12-31 $-0.06B $0.28B -32.20%
2014-09-30 $-0.05B $0.18B -33.75%
2014-06-30 $-0.04B $0.19B -30.52%
2014-03-31 $-0.05B $0.09B -45.43%
2013-12-31 $-0.07B $0.10B -157.78%
2013-09-30 $-0.07B $0.11B 1340.00%
2013-06-30 $-0.05B $0.11B 172.80%
2013-03-31 $-0.04B $-0.14B 64.41%
2012-12-31 $-0.01B $-0.10B 43.56%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.188B $0.007B
Chimerix, Inc. engages in the discovery, development and commercialization of oral antiviral therapeutics for various medical needs. The Company is developing various product candidates for the treatment of dsDNA viruses, HIV, hepatitis C, influenza and smallpox which are under different phases of clinical development. It is also screening our proprietary Chimerix Chemical Library for compounds with activity against dengue virus, malaria and tuberculosis. Chimerix, Inc. is headquartered in Durham, North Carolina.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.050B 28.74
Medtronic (MDT) Ireland $133.110B 19.01
Stryker (SYK) United States $77.009B 27.48
Boston Scientific (BSX) United States $58.755B 28.17
Baxter (BAX) United States $41.655B 26.25
EssilorLuxottica Societe Anonyme (ESLOY) France $29.025B 0.00
Coloplast (CLPBY) Denmark $25.553B 40.79
Zimmer Biomet Holdings (ZBH) United States $24.699B 15.87
Lonza Group Ag (LZAGY) Switzerland $24.641B 0.00
Terumo (TRUMY) Japan $23.393B 26.90
Smith & Nephew SNATS (SNN) United Kingdom $19.003B 0.00
ResMed (RMD) United States $17.837B 34.08
Sunny Optical Technology (SNPTF) China $12.027B 0.00
Canopy Growth (CGC) Canada $11.829B 0.00
Bio-Rad Laboratories (BIO) United States $9.215B 48.85
William Demant Holdings (WILYY) Denmark $7.651B 0.00
Insulet (PODD) United States $7.176B 522.83
Perrigo (PRGO) Ireland $7.039B 11.90
Hill-Rom Holdings (HRC) United States $6.945B 21.06
Aurora Cannabis (ACB) Canada $6.865B 67.70
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.279B 51.26
GW Pharmaceuticals (GWPH) United Kingdom $5.201B 0.00
ICU Medical (ICUI) United States $5.129B 30.60
Neogen (NEOG) United States $3.284B 53.39
NuVasive (NUVA) United States $2.961B 24.18
Hutchison China MediTech (HCM) China $2.957B 0.00
Agios Pharmaceuticals (AGIO) United States $2.654B 0.00
National Vision Holdings (EYE) United States $2.458B 52.37
Quidel (QDEL) United States $2.284B 23.70
Aphria (APHA) $1.561B 0.00
Cardiovascular Systems (CSII) United States $1.537B 882.60
Phibro Animal Health (PAHC) United States $1.234B 18.49
AtriCure (ATRC) United States $1.212B 0.00
VAREX IMAGING (VREX) United States $1.174B 24.92
Lantheus Holdings (LNTH) United States $1.078B 28.62
NanoString Technologies (NSTG) United States $1.036B 0.00
PetIQ (PETQ) United States $0.971B 23.59
MacroGenics (MGNX) United States $0.775B 0.00
Omeros (OMER) United States $0.770B 0.00
Cerus (CERS) United States $0.759B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.755B 21.17
Quanterix (QTRX) United States $0.742B 0.00
TG Therapeutics (TGTX) United States $0.704B 0.00
LeMaitre Vascular (LMAT) United States $0.574B 27.78
Surmodics (SRDX) United States $0.544B 79.10
OraSure Technologies (OSUR) United States $0.532B 24.51
Meridian Bioscience (VIVO) United States $0.487B 14.90
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.392B 0.00
Vapotherm (VAPO) United States $0.354B 0.00
Utah Medical Products (UTMD) United States $0.321B 22.26
BioLife Solutions (BLFS) United States $0.318B 99.59
Zynex (ZYXI) United States $0.277B 28.53
Bovie Medical (APYX) United States $0.237B 0.00
Cytosorbents (CTSO) United States $0.227B 0.00
Owens & Minor (OMI) United States $0.200B 4.24
Rockwell Medical (RMTI) United States $0.175B 0.00
United Health Products (UEEC) United States $0.171B 0.00
Female Health (VERU) United States $0.145B 0.00
Fonar (FONR) United States $0.139B 7.30
Chembio Diagnostics (CEMI) United States $0.098B 0.00
United-Guardian (UG) United States $0.093B 20.56
Surface Oncology (SURF) United States $0.074B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 20.00
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00